EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype

Jennifer Tai, Chao-Wei Hsu, Wei-Ting Chen, Sien-Sing Yang, Cheng-Hsun Chiu, Rong-Nan Chien, Ming-Ling Chang iD

Cancer Science · 2024

DOI: 10.1111/cas.16042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Jennifer Tai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chang Gung Medical Research Program, National Science Council, Taiwan, National Science Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The impacts of patatin‐like phospholipase domain‐containing protein 3 ( PNPLA3 ) I148M‐rs738409, methylenetetrahydrofolate reductase ( MTHFR ) Ala222Val‐rs1801133, and aldehyde dehydrogenase 2 ( ALDH2 ) Glu504Lys‐rs671 on the outcomes of Taiwanese patients with steatotic liver disease (SLD) have remained elusive. An 8‐year prospective cohort study of patients with ( n = 546) and without ( n = 580) SLD (controls) was undertaken in a Taiwanese tertiary care center. The 546 SLD patients comprised 306 (56.0%) men and 240 (44.0%) women with mean ages of 53.3 and 56.4 years, respectively. Compared with the controls, SLD patients had an increased frequency of the PNPLA3 I148M‐rs738409 GG genotype (25.5 vs. 5.9%, p = 0.001). Among the SLD patients, 236 (43.1%) suffered cardiovascular events, 52 (9.5%) showed extrahepatic cancers, 13 (2.38%) experienced hepatic events, including hepatocellular carcinoma ( n = 3, 0.5%) and liver cirrhosis ( n = 8, 1.47%), and none died. The Fibrosis‐4 (FIB‐4) scores were associated with extrahepatic cancer (hazard ratio [HR] 1.325; 95% confidence interval [CI], 1.038–1.691) and cirrhosis development (HR 1.532; 95% CI, 1.055–2.224), and the PNPLA3 I148M‐rs738409 G allele ( β = 0.158, 95% CI, 0.054–0.325) was associated with the FIB‐4 score. Stratified analyses showed that the impact of the FIB‐4 score on extrahepatic cancer development was evident only in SLD patients with the PNPLA3 I148M‐rs738409 GG genotype (HR 1.543; 95% CI, 1.195–1.993) and not in patients with the GC or CC genotype. Moreover, the ALDH2 Glu504Lys‐rs671 G allele had a dose‐dependent effect on alcoholism, and the MTHFR and ALDH2 genotypes were not significantly associated with SLD patient outcomes. In conclusion, special vigilance should be exercised for emerging extrahepatic cancer in SLD patients with the PNPLA3 I148M‐rs738409 GG genotype and high FIB‐4 scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseFemaleHumansMaleMiddle AgedAldehyde Dehydrogenase, MitochondrialGenetic Predisposition to DiseaseGenotypeLiver CirrhosisPolymorphism, Single NucleotideProspective StudiesAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

ALDH2FIB-4MTHFRPNPLA3cancerfatty liver

Substanzen

Aldehyde Dehydrogenase, MitochondrialALDH2 protein, humanPNPLA3 protein, humanAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Department of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou, Taiwan.
  • Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan.
  • Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
  • Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.

ORCID-Profile: Ming-Ling Chang

Förderung

  • Chang Gung Medical Research Program
  • National Science Council, Taiwan
  • National Science Council

Zitieren

APA

Tai, J., Hsu, C. W., Chen, W. T., Yang, S. S., Chiu, C. H., Chien, R. N., & Chang, M. L. (2024). Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype. Cancer Science. https://doi.org/10.1111/cas.16042

Vancouver

Tai J, Hsu CW, Chen WT, Yang SS, Chiu CH, Chien RN, et al. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype. Cancer Science. 2024. doi:10.1111/cas.16042

BibTeX
@article{Tai2024,
  author = {Tai, Jennifer and Hsu, Chao-Wei and Chen, Wei-Ting and Yang, Sien-Sing and Chiu, Cheng-Hsun and Chien, Rong-Nan and Chang, Ming-Ling},
  title = {Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16042}
}
Kostenlos starten →